Literature DB >> 22375017

Rapid down-regulation of γc on T cells in early SIV infection correlates with impairment of T-cell function.

Huanbin Xu1, Xiaolei Wang, Bapi Pahar, Xavier Alvarez, Kelsi K Rasmussen, Andrew A Lackner, Ronald S Veazey.   

Abstract

The common γ(c) subunit molecule is shared among all γ(c) cytokines and clearly involved in T-cell function, but its role in HIV infection and immunity is not well understood. Here, we examined expression and function of γ(c) on T cells during SIV infection in Rhesus macaques. Surface γ(c) distribution was differentially expressed on CD4(+) and CD8(+) T cells, and CD4(+) naive/memory cell populations in various lymphoid tissues of normal macaques. However, surface γ(c) expression was rapidly and significantly down-regulated on T cells in acute infection with pathogenic SIV, compared to infection with a less virulent SHIV or controls and did not recover on CD8(+) T cells in the chronic stage. Moreover, the peripheral and CD4(+)T cell loss was inversely correlated with γ(c)(+) CD8(+) T cells in individual tissues. γ(c)(+) T cells were mainly functional as evidenced by higher cytokine secretion and proliferative capacity. Further in vitro experiments found that surface γ(c) expression could be down-regulated following high level of IL-7 treatment by both internalization and shedding. Down-regulation of γ(c) during early HIV/SIV infection may inhibit T-cell function, particularly of CD8(+) T cells, and, may be linked with immune failure and loss of viral containment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22375017      PMCID: PMC3360156          DOI: 10.1096/fj.11-195180

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

1.  IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion.

Authors:  Warren N D'Souza; Leo Lefrançois
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

2.  Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

Authors:  Mirko Paiardini; Barbara Cervasi; Helmut Albrecht; Alagarraju Muthukumar; Richard Dunham; Shari Gordon; Henry Radziewicz; Giuseppe Piedimonte; Mauro Magnani; Maria Montroni; Susan M Kaech; Amy Weintrob; John D Altman; Donald L Sodora; Mark B Feinberg; Guido Silvestri
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

3.  Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression.

Authors:  Huanbin Xu; Xiaolei Wang; Bapi Pahar; Terri Moroney-Rasmussen; Xavier Alvarez; Andrew A Lackner; Ronald S Veazey
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

4.  Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.

Authors:  N T Parkin; Y S Lie; N Hellmann; M Markowitz; S Bonhoeffer; D D Ho; C J Petropoulos
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

5.  The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

Authors:  Ronald Mitsuyasu; Rebecca Gelman; Deborah Weng Cherng; Alan Landay; John Fahey; Richard Reichman; Alejo Erice; R Pat Bucy; J Michael Kilby; Michael M Lederman; Carol D Hamilton; Juan Lertora; Becky L White; Pablo Tebas; Anne-Marie Duliege; Richard B Pollard
Journal:  Arch Intern Med       Date:  2007-03-26

Review 6.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

7.  Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice.

Authors:  M J Maeurer; P Trinder; G Hommel; W Walter; K Freitag; D Atkins; S Störkel
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 8.  Disruption of the gamma c cytokine network in T cells during HIV infection.

Authors:  Danylo Sirskyj; Jacques Thèze; Ashok Kumar; Marko Kryworuchko
Journal:  Cytokine       Date:  2008-04-15       Impact factor: 3.861

Review 9.  Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways.

Authors:  Panu E Kovanen; Warren J Leonard
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

10.  Early divergent host responses in SHIVsf162P3 and SIVmac251 infected macaques correlate with control of viremia.

Authors:  Huanbin Xu; Xiaolei Wang; Lisa A Morici; Bapi Pahar; Ronald S Veazey
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

View more
  3 in total

1.  Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques.

Authors:  Amanda K Steele; Lorna Carrasco-Medina; Donald L Sodora; Angela M Crawley
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

2.  Systemic and Intestinal Viral Reservoirs in CD4+ T Cell Subsets in Primary SIV Infection.

Authors:  Xiaolei Wang; Widade Ziani; Ronald S Veazey; Huanbin Xu
Journal:  Viruses       Date:  2021-11-30       Impact factor: 5.048

3.  Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy.

Authors:  Bhawna Poonia; C David Pauza
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.